| |
Advancing Hepatitis C Elimination: Implementation Strategy for the Proposed National Program; policy brief from Duke-Margolis Center
|
| |
| |
Download the PDF here
Published date
December 5, 2023
Millions of Americans suffer from chronic hepatitis C, which remains the leading cause of liver cancer and liver transplantation, despite the availability of diagnostic tests and curative therapies. The Biden Administration has proposed a national program for hepatitis C elimination that prioritizes the development of point of care diagnostics, broad access to curative DAA therapy , and comprehensive and coordinated efforts across public health and health care programs to engage, inform, identify, and treat individuals with hepatitis C. Consequently, there is unprecedented interest in developing a feasible implementation pathway to ensure maximum impact of new federal investments needed to implement such a program. This policy brief outlines recommendations for an implementation strategy for this national program.
In collaboration with stakeholders and experts, the Duke-Margolis Center developed a strategic framework for a national hepatitis C elimination program with the goal of informing an implementation pathway for the Administration’s proposal. The framework reflected learnings from a broad range of successful local and regional programs as described above, including “test to treat” initiatives embedded in community based primary care models; effective management of COVID-19 and other respiratory pathogens resulting from improved diagnostic technologies and public health analytics; and provider payment reforms with greater accountability for important population health outcomes.
| |
| |
| |
|
|
|
